Long Term Angiotensin Converting Enzyme-inhibition in Patients after Coronary Artery Bypass Grafting Reduces Levels of Soluble Intercellular Cell Adhesion Molecule-1-Reference-Cited by-同舟云学术

Long Term Angiotensin Converting Enzyme-inhibition in Patients after Coronary Artery Bypass Grafting Reduces Levels of Soluble Intercellular Cell Adhesion Molecule-1

Published:2003-10 Issue:4 Volume:26 Page:387-391
ISSN:1078-5884
Container-title:European Journal of Vascular and Endovascular Surgery
language:en
Short-container-title:European Journal of Vascular and Endovascular Surgery

Author:

van Haelst P.L.,Cohen Tervaert J.W.,van Geel P.P.,Veeger N.J.G.M.,Gurné O.,Gans R.O.B.,van Gilst W.H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference33 articles.

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators;Yusuf;N Engl J Med,2000

2. ACE inhibition in cardiovascular disease;Francis;N Engl J Med,2000

3. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size;Lazar;Ann Thorac Surg,2001

4. Essential hypertension: renin and aldosterone, heart attack and stroke;Brunner;N Engl J Med,1972

5. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction;Cambien;Nature,1992

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Mayo Clinic Proceedings;2022-10

2. Effects of inhibitors of the renin‐angiotensin system on reducing blood pressure and expression of inflammatory factors in CHD patients: A network meta‐analysis;Journal of Cellular Physiology;2018-12-07

3. Which patients should be on renin–angiotensin system blockers after coronary surgery?: Table 1:;Interactive CardioVascular and Thoracic Surgery;2014-07-04

4. Limiting inflammatory response to cardiopulmonary bypass: pharmaceutical strategies;Current Opinion in Pharmacology;2012-04

5. Treatment of hypertension in patients undergoing coronary artery by-pass grafting;Current Opinion in Pharmacology;2012-04